API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.prnewswire.com/news-releases/quantum-leap-healthcare-collaborative-discontinues-testing-of-aerpio-pharmaceuticals-razuprotafib-in-i-spy-covid-trial-301241760.html
https://www.globenewswire.com/news-release/2021/01/05/2153803/0/en/Aerpio-Announces-Strategic-Review-after-Topline-Results-from-Razuprotafib-Glaucoma-Phase-2-Trial.html
https://www.globenewswire.com/news-release/2020/12/11/2144068/0/en/Aerpio-Announces-Statistically-Significant-Topline-Results-from-Razuprotafib-Glaucoma-Phase-2-Trial.html
https://www.globenewswire.com/news-release/2020/08/04/2072868/0/en/Aerpio-Pharmaceuticals-Inc-Announces-a-Second-Clinical-Trial-with-Funding-from-MTEC-to-Evaluate-Razuprotafib-for-the-Prevention-and-Treatment-of-ARDS-in-Patients-with-Moderate-to-S.html
https://www.clinicaltrialsarena.com/news/aerpio-quantum-razuprotafib-ards/
https://www.globenewswire.com/news-release/2020/05/27/2039771/0/en/Aerpio-Pharmaceuticals-Inc-and-Quantum-Leap-Healthcare-Collaborative-Announce-the-Selection-of-Razuprotafib-for-Evaluation-in-the-I-SPY-COVID-Trial-for-the-Treatment-of-Acute-Respi.html